Target intelligence / Profile preview

Human Papillomavirus Type 6 Major Capsid Protein (L1) (None)

Target
None
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The major capsid protein L1 from human papillomavirus type 6 is essential for virus assembly and infectivity. Its ability to form highly immunogenic virus-like particles has been harnessed successfully for preventive vaccines against multiple clinically relevant HPV types including those causing genital warts and cancers. Its structure-function relationship—especially its capacity to mimic native virions—makes it a cornerstone target molecule both biologically and therapeutically.

Other names
Human papillomavirus type 6 L1 capsid protein antigenRecombinant human papillomavirus type 6 L1 proteinL1 protein, Human papillomavirus type 6 Vaccine
02

Mechanism of action

Induction of neutralizing antibodies through VLP presentation of L1 epitopes

03

Biological functions

Viral capsid formationGenome protectionVirus assemblyInfectivityImmunogen
04

Disease associations

InfectionGenital warts (HPV-6 related)
05

Interacting drugs

Gardasil (vaccine)

Beyond the preview

Go deeper on Human Papillomavirus Type 6 Major Capsid Protein (L1) (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Papillomavirus Type 6 Major Capsid Protein (L1) (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call